查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529612

诊断酵素市场规模、份额和趋势分析：2024-2030 年按类型、应用、产品、最终用途、地区和细分市场进行的预测

Diagnostic Enzymes Market Size, Share & Trends Analysis Report By Type (Taq Polymerase, MMLV RT, HIV RT), By Application (Diabetes, Oncology, Cardiology), By Product, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10个工作天内

价格

诊断酵素市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球诊断酶市场规模将达到62.7亿美元，2024年至2030年复合年增长率为5.18%。

诊断酶市场的成长归因于对在病理学中广泛应用的诊断酶的需求不断增加。此外，病毒感染诊断技术的进步预计将推动市场成长。

由于酶活性提供的高灵敏度和准确性，诊断酶被广泛采用。酶活性可以比临床症状或其他诊断指标更早检测到。生物感测器是医疗诊断、病原体检测和监测的热门工具。生物感测器因其准确性、灵敏度、选择性和可常规使用的快速检测策略而受到欢迎。血清酵素水平的诊断已被用作细胞损伤的指标，导致细胞间成分释放到血流中。

呼吸道病毒感染疾病是最常见的人类疾病之一，由 COVID-19 等新出现的病毒爆发引起的感染疾病对公共卫生构成威胁。因此，检测病毒病原体对于预防此类流行病的发生和防止不必要的抗生素使用至关重要。因此，主要参与者正在采用新的诊断策略。 LightMix（罗氏分子诊断公司，瑞士）、AccuPower（Bioneer，韩国）、PowerChek（Kogene Biotech，韩国）、Anyplex（Seegene，韩国）、UltraFast 试剂盒（Nanobiosys，韩国）、DiaPlexQ（SolGent，韩国）它是市出售的RNA 检测RT-PCR套件的一部分，灵敏度高达 99.03%。

随着诊断酶测试数量的增加，关于其性能的论文发表了更多，建议和指南也随之增加。此外，报销途径缺乏明确的指导方针和系统的卫生技术评估（HTA）。多种因素影响付款人对诊断酶测试的决定，包括 FDA 批准、医生认可和临床指南、竞争对手覆盖政策、成本/效益分析、HTA 结果、雇主和支持团体的要求。

此外，该市场的主要企业都致力于扩大和推出可用于广泛应用的产品。例如，2022年3月，Meridian Bioscience, Inc.推出了两种可用于非侵入性液态切片的预混液。与传统的精製核酸 qPCR 相比，此类突破性技术的推出可实现卓越的分析性能水准。

诊断酵素市场报告亮点

  • 2023年，由于生物体中酵素含量丰富，葡萄糖氧化酵素/葡萄糖去氢酵素酶领域占据主导市场份额。
  • 在预测期内，由于人群中癌症盛行率不断增加，肿瘤部分预计将以最快的速度增长。
  • 由于对研发的日益关注，临床细分市场将成为 2023 年创收最高的收益市场。
  • 随着主要市场参与者专注于产品发布和地理扩张以维持其市场地位，诊断酶市场正在发生变化。
  • 由于製造设施的改善和目标人口的存在，预计亚太地区在预测期内将出现最快的增长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章诊断酵素市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 诊断酵素市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 管道分析

第四章诊断酵素市场：类型估计与趋势分析

  • 全球诊断酶市场：类型仪表板
  • 全球诊断酵素市场：类型变异分析
  • 全球诊断酵素市场，按类型、收益
  • Taq聚合酵素
  • MMLV RT
  • HIV RT
  • Hot Start Taq Pol
  • UNG
  • 核糖核酸酶抑制剂
  • Bst聚合酵素（LAMP酶）
  • PCR预混液
  • 冻干聚合酵素
  • T7 RNA聚合酵素
  • Cas9酶
  • 酸性磷酸酶
  • 丙氨酸胺基转移酶
  • 碱性磷酸酶
  • 淀粉酶
  • 血管收缩素转化酵素
  • 天门冬胺酸胺基转移酶
  • 胆碱酯酶
  • 肌酸酐激酶
  • γ谷氨酰转移酶
  • 乳酸脱氢酵素
  • 列宁
  • 葡萄糖氧化酵素/葡萄糖去氢酵素
  • 尿素酶
  • 乳酸氧化酶
  • 过氧化氢辣根
  • 麸胺酸氧化酶
  • 其他的

第五章诊断酵素市场：应用估算与趋势分析

  • 全球诊断酵素市场：应用仪表板
  • 全球诊断酵素市场：应用变化分析
  • 按使用情况分類的收益
  • 糖尿病
  • 瘤
  • 心臟病
  • 感染疾病
  • 肾臟病学
  • 自体免疫疾病
  • 其他的

第六章诊断酵素市场：产品估算与趋势分析

  • 全球诊断酵素市场：产品仪表板
  • 全球诊断酵素市场：产品变异分析
  • 按产品分類的收益
  • 分子酵素
  • 临床酶

第七章诊断酵素市场：最终用途估计与趋势分析

  • 全球诊断酵素市场：最终用途仪表板
  • 全球诊断酵素市场：最终用途变化分析
  • 按最终用途分類的收益
  • 医院
  • 临床实验室
  • 其他的

第 8 章诊断酵素市场：区域估计和趋势分析，按类型、按应用、按产品、按最终用途

  • 区域仪表板
  • 2018年至2030年市场规模与预测/趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 公司/竞争对手分类
  • 供应商情况
    • Takara Bio, Inc.
    • Promega Corporation
    • Enzo Biochem Inc.
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Creative Enzymes
    • F. Hoffmann-La Roche Ltd.
    • Solis BioDyne.
    • Ambliqon A/S.
    • Yashraj Biotechnology Ltd.
Product Code: GVR-4-68040-003-4

Diagnostic Enzymes Market Growth & Trends:

The global diagnostic enzymes market size is expected to reach USD 6.27 billion by 2030, registering a CAGR of 5.18 % from 2024 to 2030, according to a new report by Grand View Research, Inc. Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Diagnostic Enzymes Market Report Highlights:

  • In 2023, the glucose oxidase/glucose dehydrogenase enzyme segment held a dominant share in the market owing to the presence of an abundance of enzymes in living organisms
  • The oncology segment is projected to grow at the fastest rate during the forecast period owing to the increasing prevalence of cancer among the population
  • The clinical segment is the highest revenue-generating segment in 2023 owing to the increased focus on R&D
  • The diagnostic enzyme market is witnessing change owing to the presence of key market players focusing on product launches and geographic expansion to maintain their position in the market
  • Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the presence of the target population

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. Product
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type and Application outlook
    • 2.2.2. Product outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Diagnostic Enzymes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise in the demand for enzymes in pathology
      • 3.2.1.2. Wide applications of enzymes in pathology
      • 3.2.1.3. Advancements in diagnostic testing of viral infection
      • 3.2.1.4. Increase in the demand for Point-of-Care testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of enzyme-based diagnostic tests
      • 3.2.2.2. Regulatory & reimbursement hurdles for enzyme diagnostics
  • 3.3. Diagnostic Enzymes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Diagnostic Enzymes Market: Type Estimates & Trend Analysis

  • 4.1. Global Diagnostic Enzymes Market: Type Dashboard
  • 4.2. Global Diagnostic Enzymes Market: Type Movement Analysis
  • 4.3. Global Diagnostic Enzymes Market by Treatment, Revenue
  • 4.4. Taq Polymerase
    • 4.4.1. Taq Polymerase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. MMLV RT
    • 4.5.1. MMLV RT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. HIV RT
    • 4.6.1. HIV RT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Hot Start Taq Pol
    • 4.7.1. Hot Start Taq Pol market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. UNG
    • 4.8.1. UNG market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Rnase Inhibitors
    • 4.9.1. Rnase Inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Bst Polymerase (LAMP ENZYME)
    • 4.10.1. Bst Polymerase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. PCR Master Mix
    • 4.11.1. PCR Master Mix market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.12. Lyophilized Polymerase
    • 4.12.1. Lyophilized Polymerase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.13. T7 Rna Polymerase
    • 4.13.1. T7 Rna Polymerase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.14. Cas9 Enzyme
    • 4.14.1. Cas9 Enzyme market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.15. Acid Phosphatase
    • 4.15.1. Acid Phosphatase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.16. Alanine Aminotransferase
    • 4.16.1. Alanine Aminotransferase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.17. Alkaline Phosphatase
    • 4.17.1. Alkaline Phosphatase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.18. Amylase
    • 4.18.1. Amylase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.19. Angiotensin Converting Enzyme
    • 4.19.1. Angiotensin Converting Enzyme market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.20. Aspartate Aminotransferase
    • 4.20.1. Aspartate Aminotransferase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.21. Cholinesterase
    • 4.21.1. Cholinesterase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.22. Creatinine Kinase
    • 4.22.1. Creatinine Kinase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.23. Gamma Glutamyl Transferase
    • 4.23.1. Gamma Glutamyl Transferase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.24. Lactate Dehydrogenase
    • 4.24.1. Lactate Dehydrogenase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.25. Renin
    • 4.25.1. Renin market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.26. Glucose Oxidase/Glucose Dehydrogenase
    • 4.26.1. Glucose Oxidase/Glucose Dehydrogenase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.27. Urease
    • 4.29.1. Urease market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.28. Lactate Oxidase
    • 4.31.1. Lactate Oxidase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.29. Horseradish Peroxide
    • 4.33.1. Horseradish Peroxide market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.30. Glutamate Oxidase
    • 4.35.1. Glutamate Oxidase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.31. Others
    • 4.31.1. Others Oxidase market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Diagnostic Enzymes Market: Application Estimates & Trend Analysis

  • 5.1. Global Diagnostic Enzymes Market: Application Dashboard
  • 5.2. Global Diagnostic Enzymes Market: Application Movement Analysis
  • 5.3. Global Diagnostic Enzymes Market Estimates and Forecasts, By Application, Revenue (USD Million)
  • 5.4. Diabetes
    • 5.4.1. Diabetes market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Cardiology
    • 5.6.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Infectious Disease
    • 5.7.1. Infectious Disease market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Nephrology
    • 5.8.1. Nephrology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Autoimmune Diseases
    • 5.9.1. Autoimmune Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Diagnostic Enzymes Market: Product Estimates & Trend Analysis

  • 6.1. Global Diagnostic Enzymes Market: Product Dashboard
  • 6.2. Global Diagnostic Enzymes Market: Product Movement Analysis
  • 6.3. Global Diagnostic Enzymes Market Estimates and Forecasts, by Product, Revenue (USD Million)
  • 6.4. Molecular Enzymes
    • 6.4.1. Molecular Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinical Enzymes
    • 6.5.1. Clinical Enzymes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Diagnostic Enzymes Market: End Use Estimates & Trend Analysis

  • 7.1. Global Diagnostic Enzymes Market: End Use Dashboard
  • 7.2. Global Diagnostic Enzymes Market: End Use Movement Analysis
  • 7.3. Global Diagnostic Enzymes Market Estimates and Forecasts by End Use, Revenue (USD Million)
  • 7.4. Hospital
    • 7.4.1. Hospital market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Clinical Laboratories
    • 7.5.1. Clinical Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others End -users
    • 7.6.1. Others End -users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Diagnostic Enzymes Market: Regional Estimates & Trend Analysis by Type, Application, Product and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
    • 9.2.2. Key customers
    • 9.2.3. Key company market share analysis, 2023
    • 9.2.4. Takara Bio, Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Promega Corporation
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Enzo Biochem Inc.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Merck KGaA
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Thermo Fisher Scientific, Inc.
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Creative Enzymes
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. F. Hoffmann-La Roche Ltd.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Solis BioDyne.
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Ambliqon A/S.
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Yashraj Biotechnology Ltd.
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 16 Mexico Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 23 Europe Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 26 Germany Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 28 UK Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 29 UK Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 30 UK Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 31 UK Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 33 France Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 34 France Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 35 France Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Italy Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 37 Italy Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 38 Italy Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 39 Italy Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Spain Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 41 Spain Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 42 Spain Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 43 Spain Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 45 Denmark Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 47 Denmark Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Sweden Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 49 Sweden Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 50 Sweden Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 51 Sweden Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Norway Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 53 Norway Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 54 Norway Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 55 Norway Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 61 China Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 62 China Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 63 China Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 64 China Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Japan Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 66 Japan Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 67 Japan Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 68 Japan Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 69 India Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 70 India Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 71 India Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 72 India Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 73 South Korea Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 74 South Korea Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 75 South Korea Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 76 South Korea Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Australia Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 78 Australia Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 79 Australia Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 80 Australia Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Thailand Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 82 Thailand Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 83 Thailand Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 84 Thailand Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 86 Latin America Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 87 Latin America Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 88 Latin America Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 89 Latin America Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Brazil Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 91 Brazil Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 92 Brazil Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 93 Brazil Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 95 Argentina Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 96 Argentina Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 97 Argentina Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 98 MEA Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 99 MEA Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 100 MEA Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 101 MEA Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 102 MEA Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 103 South Africa Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Africa Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 105 South Africa Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 106 South Africa Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 112 UAE Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 113 UAE Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 114 UAE Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Diagnostic Enzymes market: market outlook
  • Fig. 14 Diagnostic Enzymes competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Diagnostic Enzymes market driver impact
  • Fig. 18 Diagnostic Enzymes market restraint impact
  • Fig. 19 Diagnostic Enzymes market: Type movement analysis
  • Fig. 20 Diagnostic Enzymes market: Type outlook and key takeaways
  • Fig. 21 Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 UNG market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 RNase inhibitor market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Bst polymerase (LAMP enzyme) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 PCR Master Mix market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Lyophilised Polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Angiotensin converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Renin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Glucose oxidase/glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Urease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Horseradish peroxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Diagnostic Enzymes market: Application movement analysis
  • Fig. 50 Diagnostic Enzymes market: Application outlook and key takeaways
  • Fig. 51 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Autoimmune Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Diagnostic Enzymes market: Product movement analysis
  • Fig. 59 Diagnostic Enzymes market: Product outlook and key takeaways
  • Fig. 60 Molecular Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Clinical Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Diagnostic Enzymes market: End Use movement analysis
  • Fig. 63 Diagnostic Enzymes market: End Use outlook and key takeaways
  • Fig. 64 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Clinical Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Other End Users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Global Diagnostic Enzymes market: Regional movement analysis
  • Fig. 68 Global Diagnostic Enzymes market: Regional outlook and key takeaways
  • Fig. 69 Global Diagnostic Enzymes market share and leading players
  • Fig. 70 North America, by country
  • Fig. 71 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 U.S. key country dynamics
  • Fig. 73 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Canada key country dynamics
  • Fig. 75 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Mexico key country dynamics
  • Fig. 77 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 UK key country dynamics
  • Fig. 80 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Germany key country dynamics
  • Fig. 82 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 France key country dynamics
  • Fig. 84 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Italy key country dynamics
  • Fig. 86 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Spain key country dynamics
  • Fig. 88 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Denmark key country dynamics
  • Fig. 90 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Sweden key country dynamics
  • Fig. 92 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Norway key country dynamics
  • Fig. 94 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 China key country dynamics
  • Fig. 97 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Japan key country dynamics
  • Fig. 99 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 India key country dynamics
  • Fig. 101 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Thailand key country dynamics
  • Fig. 103 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 South Korea key country dynamics
  • Fig. 105 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Australia key country dynamics
  • Fig. 107 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Brazil key country dynamics
  • Fig. 110 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Argentina key country dynamics
  • Fig. 112 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 South Africa key country dynamics
  • Fig. 115 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 116 Saudi Arabia key country dynamics
  • Fig. 117 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 118 UAE key country dynamics
  • Fig. 119 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Kuwait key country dynamics
  • Fig. 121 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Market share of key market players- Diagnostic Enzymes market